- Apr 9, 2012

Glioma peptide vaccine shows early hints of efficacy

Generally, childhood cancers can be fairly treatable. However, some brain cancers, such as malignant astrocytomas of the brainstem and cerebral hemispheres and multiply recurrent low-grade gliomas don't respond well to treatment and the outcomes are not good for the patient. Adult gliomas can be treated with immunotherapies, and a group from the University of Pittsburgh Cancer Institute decided to see how the approach would work in children.

Recent Posts

Glioma peptide vaccine shows early hints of efficacy

Study: Nearly 20 years on, no adverse impacts for pediatric cancer patients treated with dexrazoxan

Surviving cancer as a child can affect lifelong health

Drug combination highly effective in children with standard-and high-risk APL

Safety concerns raised for neuroblastoma candidate drug